Annual Cash & Cash Equivalents
$33.11 M
-$17.59 M-34.70%
December 31, 2023
Summary
- As of February 7, 2025, OFIX annual cash & cash equivalents is $33.11 million, with the most recent change of -$17.59 million (-34.70%) on December 31, 2023.
- During the last 3 years, OFIX annual cash & cash equivalents has fallen by -$63.18 million (-65.62%).
- OFIX annual cash & cash equivalents is now -65.62% below its all-time high of $96.29 million, reached on December 31, 2020.
Performance
OFIX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$30.05 M
+$3.69 M+13.99%
September 30, 2024
Summary
- As of February 7, 2025, OFIX quarterly cash and cash equivalents is $30.05 million, with the most recent change of +$3.69 million (+13.99%) on September 30, 2024.
- Over the past year, OFIX quarterly cash and cash equivalents has dropped by -$3.61 million (-10.72%).
- OFIX quarterly cash and cash equivalents is now -82.62% below its all-time high of $172.89 million, reached on June 30, 2020.
Performance
OFIX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
OFIX Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -34.7% | -10.7% |
| 3 y3 years | -65.6% | -20.1% |
| 5 y5 years | -52.5% | -47.1% |
OFIX Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -62.3% | at low | -65.8% | +14.0% |
| 5 y | 5-year | -65.6% | at low | -82.6% | +14.0% |
| alltime | all time | -65.6% | +819.6% | -82.6% | +734.8% |
Orthofix Medical Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $30.05 M(+14.0%) |
| Jun 2024 | - | $26.37 M(-2.2%) |
| Mar 2024 | - | $26.96 M(-18.6%) |
| Dec 2023 | $33.11 M(-34.7%) | $33.11 M(-1.7%) |
| Sep 2023 | - | $33.66 M(-10.5%) |
| Jun 2023 | - | $37.61 M(-24.7%) |
| Mar 2023 | - | $49.97 M(-1.4%) |
| Dec 2022 | $50.70 M(-42.3%) | $50.70 M(-1.9%) |
| Sep 2022 | - | $51.66 M(-13.2%) |
| Jun 2022 | - | $59.54 M(-17.2%) |
| Mar 2022 | - | $71.92 M(-18.1%) |
| Dec 2021 | $87.85 M(-8.8%) | $87.85 M(+6.2%) |
| Sep 2021 | - | $82.71 M(+3.4%) |
| Jun 2021 | - | $79.97 M(-15.4%) |
| Mar 2021 | - | $94.57 M(-1.8%) |
| Dec 2020 | $96.29 M(+38.1%) | $96.29 M(+20.7%) |
| Sep 2020 | - | $79.81 M(-53.8%) |
| Jun 2020 | - | $172.89 M(+199.4%) |
| Mar 2020 | - | $57.74 M(-17.2%) |
| Dec 2019 | $69.72 M(+0.1%) | $69.72 M(+22.6%) |
| Sep 2019 | - | $56.85 M(+9.0%) |
| Jun 2019 | - | $52.14 M(+11.7%) |
| Mar 2019 | - | $46.67 M(-33.0%) |
| Dec 2018 | $69.62 M(-14.2%) | $69.62 M(+29.5%) |
| Sep 2018 | - | $53.78 M(+17.7%) |
| Jun 2018 | - | $45.69 M(-40.7%) |
| Mar 2018 | - | $77.06 M(-5.1%) |
| Dec 2017 | $81.16 M(+105.1%) | $81.16 M(+50.5%) |
| Sep 2017 | - | $53.92 M(+21.6%) |
| Jun 2017 | - | $44.33 M(+6.4%) |
| Mar 2017 | - | $41.65 M(+5.3%) |
| Dec 2016 | $39.57 M(-37.8%) | $39.57 M(-15.5%) |
| Sep 2016 | - | $46.82 M(+15.7%) |
| Jun 2016 | - | $40.48 M(+1.6%) |
| Mar 2016 | - | $39.85 M(-37.4%) |
| Dec 2015 | $63.66 M(+72.9%) | $63.66 M(-0.0%) |
| Sep 2015 | - | $63.69 M(+13.8%) |
| Jun 2015 | - | $55.95 M(+87.8%) |
| Mar 2015 | - | $29.78 M(-19.1%) |
| Dec 2014 | $36.81 M(+27.3%) | $36.81 M(+23.4%) |
| Sep 2014 | - | $29.82 M(+3.1%) |
| Jun 2014 | - | $28.92 M(+8.1%) |
| Mar 2014 | - | $26.75 M(-7.5%) |
| Dec 2013 | $28.92 M(-6.0%) | $28.92 M(+30.2%) |
| Sep 2013 | - | $22.22 M(-18.8%) |
| Jun 2013 | - | $27.37 M(-18.7%) |
| Mar 2013 | - | $33.67 M(+9.5%) |
| Dec 2012 | $30.77 M(-7.3%) | $30.77 M(-42.6%) |
| Sep 2012 | - | $53.57 M(+7.0%) |
| Jun 2012 | - | $50.09 M(+6.5%) |
| Mar 2012 | - | $47.05 M(+41.7%) |
| Dec 2011 | $33.21 M(+144.9%) | $33.21 M(+14.4%) |
| Sep 2011 | - | $29.02 M(+5.6%) |
| Jun 2011 | - | $27.48 M(+17.5%) |
| Mar 2011 | - | $23.39 M(+72.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2010 | $13.56 M(+1.7%) | $13.56 M(-11.1%) |
| Sep 2010 | - | $15.25 M(-22.6%) |
| Jun 2010 | - | $19.69 M(+5.0%) |
| Mar 2010 | - | $18.76 M(+40.7%) |
| Dec 2009 | $13.33 M(-8.7%) | $13.33 M(+96.0%) |
| Sep 2009 | - | $6.80 M(+14.9%) |
| Jun 2009 | - | $5.92 M(-13.2%) |
| Mar 2009 | - | $6.82 M(-53.3%) |
| Dec 2008 | $14.59 M(-41.8%) | $14.59 M(+41.9%) |
| Sep 2008 | - | $10.29 M(-38.9%) |
| Jun 2008 | - | $16.84 M(-37.0%) |
| Mar 2008 | - | $26.73 M(+6.7%) |
| Dec 2007 | $25.06 M(-3.2%) | $25.06 M(+6.4%) |
| Sep 2007 | - | $23.56 M(+50.2%) |
| Jun 2007 | - | $15.68 M(-28.1%) |
| Mar 2007 | - | $21.80 M(-15.7%) |
| Dec 2006 | $25.88 M(-59.4%) | $25.88 M(-30.3%) |
| Sep 2006 | - | $37.11 M(-25.7%) |
| Jun 2006 | - | $49.96 M(+2.8%) |
| Mar 2006 | - | $48.60 M(-23.8%) |
| Dec 2005 | $63.79 M(+145.9%) | $63.79 M(-31.8%) |
| Sep 2005 | - | $93.47 M(+364.0%) |
| Jun 2005 | - | $20.14 M(-22.6%) |
| Mar 2005 | - | $26.02 M(+0.3%) |
| Dec 2004 | $25.94 M(-17.3%) | $25.94 M(-32.7%) |
| Sep 2004 | - | $38.53 M(-16.2%) |
| Jun 2004 | - | $46.01 M(+14.8%) |
| Mar 2004 | - | $40.07 M(+27.8%) |
| Dec 2003 | $31.36 M(-35.8%) | $31.36 M(-31.4%) |
| Sep 2003 | - | $45.73 M(+18.2%) |
| Jun 2003 | - | $38.68 M(-6.9%) |
| Mar 2003 | - | $41.55 M(-14.9%) |
| Dec 2002 | $48.81 M(+42.4%) | $48.81 M(+20.7%) |
| Sep 2002 | - | $40.45 M(+10.8%) |
| Jun 2002 | - | $36.52 M(+15.6%) |
| Mar 2002 | - | $31.59 M(-7.8%) |
| Dec 2001 | $34.27 M(-32.1%) | $34.27 M(-24.4%) |
| Jun 2001 | - | $45.36 M(+3.9%) |
| Mar 2001 | - | $43.64 M(-13.5%) |
| Dec 2000 | $50.46 M(+418.9%) | $50.46 M(-10.6%) |
| Sep 2000 | - | $56.44 M(-6.0%) |
| Jun 2000 | - | $60.07 M(+2.5%) |
| Mar 2000 | - | $58.59 M(+502.5%) |
| Dec 1999 | $9.72 M(+38.9%) | $9.72 M(-18.3%) |
| Sep 1999 | - | $11.90 M(+52.6%) |
| Jun 1999 | - | $7.80 M(-27.8%) |
| Mar 1999 | - | $10.80 M(+54.3%) |
| Dec 1998 | $7.00 M(+70.7%) | $7.00 M(+70.7%) |
| Dec 1997 | $4.10 M(+13.9%) | $4.10 M(+13.9%) |
| Dec 1996 | $3.60 M(-48.6%) | $3.60 M(-48.6%) |
| Dec 1995 | $7.00 M(-65.9%) | $7.00 M(-71.2%) |
| Mar 1995 | - | $24.30 M(+18.5%) |
| Dec 1994 | $20.50 M(+19.2%) | $20.50 M(+7.3%) |
| Jun 1994 | - | $19.10 M(+11.0%) |
| Dec 1993 | $17.20 M(+13.2%) | $17.20 M(+13.2%) |
| Dec 1992 | $15.20 M | $15.20 M |
FAQ
- What is Orthofix Medical annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Orthofix Medical?
- What is Orthofix Medical annual cash & cash equivalents year-on-year change?
- What is Orthofix Medical quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Orthofix Medical?
- What is Orthofix Medical quarterly cash and cash equivalents year-on-year change?
What is Orthofix Medical annual cash & cash equivalents?
The current annual cash & cash equivalents of OFIX is $33.11 M
What is the all time high annual cash & cash equivalents for Orthofix Medical?
Orthofix Medical all-time high annual cash & cash equivalents is $96.29 M
What is Orthofix Medical annual cash & cash equivalents year-on-year change?
Over the past year, OFIX annual cash & cash equivalents has changed by -$17.59 M (-34.70%)
What is Orthofix Medical quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of OFIX is $30.05 M
What is the all time high quarterly cash and cash equivalents for Orthofix Medical?
Orthofix Medical all-time high quarterly cash and cash equivalents is $172.89 M
What is Orthofix Medical quarterly cash and cash equivalents year-on-year change?
Over the past year, OFIX quarterly cash and cash equivalents has changed by -$3.61 M (-10.72%)